Trial Details

COMPLETED
Basic Information
Clinical ID c4698
Identifier NCT00102921
Trial Title Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn Disease
Interventions DRUG: CCX282-B
Participant Information
Sponsor Amgen
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2004-08
Primary Completion Date -
Completion Date 2005-12